Skip to content

Survey of Usage Monitoring of Midazolam and Arousal Level of Flumazenil in Endoscopy

Survey of Usage Monitoring of Midazolam and Arousal Level of Flumazenil in Endoscopy - Survey of Usage Monitoring of Midazolam and Flumazenil in Endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000007848
Enrollment
400
Registered
2012-04-27
Start date
2012-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease of the need for Gastrointestinal Endoscopy

Interventions

None listed

Sponsors

Secomedic Hospital
Lead Sponsor
Chiba Pharmaceutical Association Drug Information Center
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Range in age from 20 to 60

Exclusion criteria

Exclusion criteria: 1)Case where no consent is obtained. 2)Contraindication or caution to Midazolam or Flumazenil. 3)Acute disease(infection,gastrointestinal bleeding etc.). 4)Therapeutic purpose.

Design outcomes

Primary

MeasureTime frame
Relationship with drinking history, drug history and BMI

Countries

Japan

Contacts

Public ContactHiroyuki Nagasawa

Secomedic Hospital Department of Pharmacy

hiroyu-nagasawa@secom.co.jp047-457-9255

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026